Advertisement
Advertisement
U.S. markets open in 12 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Lee Pharmaceuticals, Inc. (LPHM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2500-0.0200 (-7.41%)
At close: 02:14PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.2700
Open0.2400
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.2400 - 0.2600
52 Week Range0.0001 - 1.1900
Volume10,500
Avg. Volume11,162
Market Cap248,876
Beta (5Y Monthly)872.27
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for LPHM

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • LEE PHARMACEUTICALS
    Analyst Report: Colgate-Palmolive CompanySince its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more
  • GlobeNewswire

    LEE PHARMACEUTICALS (LPHM) PROVIDES SHAREHOLDER UPDATE AND ANNOUNCES CHANGE OF CONTROL

    Sheridan, Wyoming, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Publicly-held Lee Pharmaceuticals (OTC Pink: LPHM) announces the completion of a change of control with Accelerate Global Market Solutions, Corp (AGMSC), Inc. in which AGMSC acquired control of the company’s Special Series A Preferred in a private transaction with Synergy Management and confirmation of LPHM’s business model shift to the Technology & Security sector. As part of the transaction, John Morgan was appointed as sole officer and Benj

Advertisement
Advertisement